Last 12 months
Inside the activity.
0 purchase rows · 42 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 17 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 02, 2017 Filed Feb 6, 2017 17:14 UTC |
Frazier Healthcare V, LP10% owner
FHM V, LP10% owner
FHM V, LLC10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
OtherWarrants · Derivative | 117,235 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001012975-17-000091 · edgar.xml · derivative · entry 2 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 117,235 shares Expires 2018-11-04 F1 · derivative.exercise_date: This warrant is exercisable at any time. F2 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 17:14 UTC |
Frazier Healthcare V, LP10% owner
FHM V, LP10% owner
FHM V, LLC10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
OtherCommon Stock | 117,235 | $4.55 | $533,419.25 |
DisclosureSEC source: 0001012975-17-000091 · edgar.xml · nonDerivative · entry 1 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,345,612 F2 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC |
Frazier Healthcare VII, L.P.10% owner
Frazier Healthcare VII-A, L.P.10% owner
FHM VII, L.P.10% owner
FHM VII, L.L.C.10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionSeries D Preferred Stock · Derivative | 209,095 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · derivative · entry 12 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 209,095 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F4 · derivative.exercise_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F4 · derivative.expiration_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F7 · derivative.underlying_shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC |
Frazier Healthcare VII, L.P.10% owner
Frazier Healthcare VII-A, L.P.10% owner
FHM VII, L.P.10% owner
FHM VII, L.L.C.10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionSeries D Preferred Stock · Derivative | 733,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · derivative · entry 11 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 733,740 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F4 · derivative.exercise_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F4 · derivative.expiration_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F6 · derivative.underlying_shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F6 · ownership.direct: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC |
Frazier Healthcare VII, L.P.10% owner
Frazier Healthcare VII-A, L.P.10% owner
FHM VII, L.P.10% owner
FHM VII, L.L.C.10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionSeries C-1 Preferred Stock · Derivative | 195,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · derivative · entry 10 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 195,751 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F3 · derivative.exercise_date: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F3 · derivative.expiration_date: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC |
Frazier Healthcare VII, L.P.10% owner
Frazier Healthcare VII-A, L.P.10% owner
FHM VII, L.P.10% owner
FHM VII, L.L.C.10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionSeries C Preferred Stock · Derivative | 604,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · derivative · entry 9 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 604,055 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F2 · derivative.exercise_date: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F2 · derivative.expiration_date: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC |
Frazier Healthcare VII, L.P.10% owner
Frazier Healthcare VII-A, L.P.10% owner
FHM VII, L.P.10% owner
FHM VII, L.L.C.10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionSeries B Preferred Stock · Derivative | 1,428,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · derivative · entry 8 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,428,571 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F1 · derivative.exercise_date: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F1 · derivative.expiration_date: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC |
Frazier Healthcare VII, L.P.10% owner
Frazier Healthcare VII-A, L.P.10% owner
FHM VII, L.P.10% owner
FHM VII, L.L.C.10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
PurchaseCommon Stock | 88,709 | $15.00 | $1,330,635.00 |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 7 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 88,709 F7 · shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC |
Frazier Healthcare VII, L.P.10% owner
Frazier Healthcare VII-A, L.P.10% owner
FHM VII, L.P.10% owner
FHM VII, L.L.C.10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
PurchaseCommon Stock | 311,291 | $15.00 | $4,669,365.00 |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 6 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,291 F6 · shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F6 · ownership.direct: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC |
Frazier Healthcare VII, L.P.10% owner
Frazier Healthcare VII-A, L.P.10% owner
FHM VII, L.P.10% owner
FHM VII, L.L.C.10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionCommon Stock | 209,095 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 5 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 209,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F4 · price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC |
Frazier Healthcare VII, L.P.10% owner
Frazier Healthcare VII-A, L.P.10% owner
FHM VII, L.P.10% owner
FHM VII, L.L.C.10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionCommon Stock | 733,740 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 4 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 733,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F4 · price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F6 · ownership.direct: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC |
Frazier Healthcare VII, L.P.10% owner
Frazier Healthcare VII-A, L.P.10% owner
FHM VII, L.P.10% owner
FHM VII, L.L.C.10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionCommon Stock | 195,751 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 3 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 195,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F3 · price: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC |
Frazier Healthcare VII, L.P.10% owner
Frazier Healthcare VII-A, L.P.10% owner
FHM VII, L.P.10% owner
FHM VII, L.L.C.10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionCommon Stock | 604,055 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 2 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 604,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F2 · price: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:20 UTC |
Frazier Healthcare VII, L.P.10% owner
Frazier Healthcare VII-A, L.P.10% owner
FHM VII, L.P.10% owner
FHM VII, L.L.C.10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionCommon Stock | 1,428,571 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 1 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,428,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F1 · price: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC |
Frazier Healthcare V, LP10% owner
FHM V, LP10% owner
FHM V, LLC10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionSeries D Preferred Stock · Derivative | 209,095 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · derivative · entry 12 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 209,095 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F4 · derivative.exercise_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F4 · derivative.expiration_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F7 · derivative.underlying_shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC |
Frazier Healthcare V, LP10% owner
FHM V, LP10% owner
FHM V, LLC10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionSeries D Preferred Stock · Derivative | 733,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · derivative · entry 11 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 733,740 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F4 · derivative.exercise_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F4 · derivative.expiration_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F6 · derivative.underlying_shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F6 · ownership.nature: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC |
Frazier Healthcare V, LP10% owner
FHM V, LP10% owner
FHM V, LLC10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionSeries C-1 Preferred Stock · Derivative | 195,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · derivative · entry 10 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 195,751 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F3 · derivative.exercise_date: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F3 · derivative.expiration_date: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC |
Frazier Healthcare V, LP10% owner
FHM V, LP10% owner
FHM V, LLC10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionSeries C Preferred Stock · Derivative | 604,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · derivative · entry 9 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 604,055 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F2 · derivative.exercise_date: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F2 · derivative.expiration_date: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC |
Frazier Healthcare V, LP10% owner
FHM V, LP10% owner
FHM V, LLC10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionSeries B Preferred Stock · Derivative | 1,428,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · derivative · entry 8 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,428,571 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F1 · derivative.exercise_date: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F1 · derivative.expiration_date: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC |
Frazier Healthcare V, LP10% owner
FHM V, LP10% owner
FHM V, LLC10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
PurchaseCommon Stock | 88,709 | $15.00 | $1,330,635.00 |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 7 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 88,709 F7 · shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC |
Frazier Healthcare V, LP10% owner
FHM V, LP10% owner
FHM V, LLC10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
PurchaseCommon Stock | 311,291 | $15.00 | $4,669,365.00 |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 6 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 311,291 F6 · shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F6 · ownership.nature: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC |
Frazier Healthcare V, LP10% owner
FHM V, LP10% owner
FHM V, LLC10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionCommon Stock | 209,095 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 5 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 209,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F4 · price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC |
Frazier Healthcare V, LP10% owner
FHM V, LP10% owner
FHM V, LLC10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionCommon Stock | 733,740 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 4 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 733,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F4 · price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F6 · ownership.nature: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC |
Frazier Healthcare V, LP10% owner
FHM V, LP10% owner
FHM V, LLC10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionCommon Stock | 195,751 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 3 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F3 · price: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC |
Frazier Healthcare V, LP10% owner
FHM V, LP10% owner
FHM V, LLC10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionCommon Stock | 604,055 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 2 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 604,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F2 · price: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 16:16 UTC |
Frazier Healthcare V, LP10% owner
FHM V, LP10% owner
FHM V, LLC10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
ConversionCommon Stock | 1,428,571 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 1 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F1 · price: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date. F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:50 UTC |
Gallagher Carol GiltnerDirector
|
ConversionSeries D Preferred Stock · Derivative | 21,439 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006405 · doc4.xml · derivative · entry 3 Gallagher Carol Giltner · CIK 0001329959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,439 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.exercise_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.expiration_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:50 UTC |
Gallagher Carol GiltnerDirector
|
ConversionSeries C Preferred Stock · Derivative | 42,857 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006405 · doc4.xml · derivative · entry 2 Gallagher Carol Giltner · CIK 0001329959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,857 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.exercise_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.expiration_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:50 UTC |
Gallagher Carol GiltnerDirector
|
ConversionCommon Stock | 64,296 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006405 · doc4.xml · nonDerivative · entry 1 Gallagher Carol Giltner · CIK 0001329959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,296 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:51 UTC |
Topper James NDirector · 10% owner
|
ConversionSeries D Preferred Stock · Derivative | 209,095 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006406 · doc4.xml · derivative · entry 10 Topper James N · CIK 0001341382 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 0 Underlying: Common Stock · 209,095 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.expiration_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F4 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Ventures. Dr. Topper is a General Partner of Frazier Healthcare. Mr. Topper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:51 UTC |
Topper James NDirector · 10% owner
|
ConversionSeries D Preferred Stock · Derivative | 733,740 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006406 · doc4.xml · derivative · entry 9 Topper James N · CIK 0001341382 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 0 Underlying: Common Stock · 733,740 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.expiration_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F3 · ownership.nature: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Ventures. Dr. Topper is a General Partner of Frazier Healthcare. Mr. Topper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:51 UTC |
Topper James NDirector · 10% owner
|
ConversionSeries C-1 Preferred Stock · Derivative | 195,751 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006406 · doc4.xml · derivative · entry 8 Topper James N · CIK 0001341382 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 0 Underlying: Common Stock · 195,751 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.expiration_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F2 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Ventures. Dr. Topper is a General Partner of Frazier Healthcare. Mr. Topper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:51 UTC |
Topper James NDirector · 10% owner
|
ConversionSeries C Preferred Stock · Derivative | 604,055 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006406 · doc4.xml · derivative · entry 7 Topper James N · CIK 0001341382 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 0 Underlying: Common Stock · 604,055 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.expiration_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F2 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Ventures. Dr. Topper is a General Partner of Frazier Healthcare. Mr. Topper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:51 UTC |
Topper James NDirector · 10% owner
|
ConversionSeries B Preferred Stock · Derivative | 1,428,571 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006406 · doc4.xml · derivative · entry 6 Topper James N · CIK 0001341382 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 0 Underlying: Common Stock · 1,428,571 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.expiration_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F2 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Ventures. Dr. Topper is a General Partner of Frazier Healthcare. Mr. Topper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:51 UTC |
Topper James NDirector · 10% owner
|
PurchaseCommon Stock | 88,709 | $15.00 | $1,330,635.00 |
DisclosureSEC source: 0001209191-17-006406 · doc4.xml · nonDerivative · entry 5 Topper James N · CIK 0001341382 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 297,804 F4 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Ventures. Dr. Topper is a General Partner of Frazier Healthcare. Mr. Topper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:51 UTC |
Topper James NDirector · 10% owner
|
PurchaseCommon Stock | 311,291 | $15.00 | $4,669,365.00 |
DisclosureSEC source: 0001209191-17-006406 · doc4.xml · nonDerivative · entry 4 Topper James N · CIK 0001341382 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 1,045,031 F3 · ownership.nature: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Ventures. Dr. Topper is a General Partner of Frazier Healthcare. Mr. Topper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:51 UTC |
Topper James NDirector · 10% owner
|
ConversionCommon Stock | 209,095 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006406 · doc4.xml · nonDerivative · entry 3 Topper James N · CIK 0001341382 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 209,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F4 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Ventures. Dr. Topper is a General Partner of Frazier Healthcare. Mr. Topper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:51 UTC |
Topper James NDirector · 10% owner
|
ConversionCommon Stock | 733,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006406 · doc4.xml · nonDerivative · entry 2 Topper James N · CIK 0001341382 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 733,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F3 · ownership.nature: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Ventures. Dr. Topper is a General Partner of Frazier Healthcare. Mr. Topper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:51 UTC |
Topper James NDirector · 10% owner
|
ConversionCommon Stock | 2,228,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006406 · doc4.xml · nonDerivative · entry 1 Topper James N · CIK 0001341382 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 2,228,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F2 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Ventures. Dr. Topper is a General Partner of Frazier Healthcare. Mr. Topper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:49 UTC |
Lydon NicholasDirector
|
ConversionSeries D Preferred Stock · Derivative | 67,345 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006404 · doc4.xml · derivative · entry 5 Lydon Nicholas · CIK 0001639935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 67,345 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.exercise_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.expiration_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:49 UTC |
Lydon NicholasDirector
|
ConversionSeries C Preferred Stock · Derivative | 55,403 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006404 · doc4.xml · derivative · entry 4 Lydon Nicholas · CIK 0001639935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,403 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.exercise_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.expiration_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:49 UTC |
Lydon NicholasDirector
|
ConversionSeries B Preferred Stock · Derivative | 80,877 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006404 · doc4.xml · derivative · entry 3 Lydon Nicholas · CIK 0001639935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,877 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.exercise_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.expiration_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:49 UTC |
Lydon NicholasDirector
|
PurchaseCommon Stock | 16,666 | $15.00 | $249,990.00 |
DisclosureSEC source: 0001209191-17-006404 · doc4.xml · nonDerivative · entry 2 Lydon Nicholas · CIK 0001639935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,623 Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:49 UTC |
Lydon NicholasDirector
|
ConversionCommon Stock | 203,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006404 · doc4.xml · nonDerivative · entry 1 Lydon Nicholas · CIK 0001639935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:47 UTC |
Londei MarcoChief Medical Officer
|
ConversionSeries D Preferred Stock · Derivative | 2,020 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006403 · doc4.xml · derivative · entry 2 Londei Marco · CIK 0001654500 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,020 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.exercise_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.expiration_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:47 UTC |
Londei MarcoChief Medical Officer
|
ConversionCommon Stock | 2,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006403 · doc4.xml · nonDerivative · entry 1 Londei Marco · CIK 0001654500 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:44 UTC |
Suria HamzaDirector · President, CEO
|
ConversionSeries D Preferred · Derivative | 2,020 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006402 · doc4.xml · derivative · entry 4 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,020 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.exercise_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.expiration_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:44 UTC |
Suria HamzaDirector · President, CEO
|
ConversionSeries C-1 Preferred · Derivative | 781 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006402 · doc4.xml · derivative · entry 3 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 781 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.exercise_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.expiration_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:44 UTC |
Suria HamzaDirector · President, CEO
|
ConversionSeries C Preferred · Derivative | 2,197 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006402 · doc4.xml · derivative · entry 2 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,197 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.exercise_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. F1 · derivative.expiration_date: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. Read SEC document |
| January 31, 2017 Filed Jan 31, 2017 21:44 UTC |
Suria HamzaDirector · President, CEO
|
ConversionCommon Stock | 4,998 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006402 · doc4.xml · nonDerivative · entry 1 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.